These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

126 related items for PubMed ID: 3094526

  • 1. On the nature of cellular ADP-ribosyltransferase from rat liver specific for elongation factor 2.
    Sayhan O, Ozdemirli M, Nurten R, Bermek E.
    Biochem Biophys Res Commun; 1986 Sep 30; 139(3):1210-4. PubMed ID: 3094526
    [Abstract] [Full Text] [Related]

  • 2. Characterization of the endogenous ADP-ribosylation of wild-type and mutant elongation factor 2 in eukaryotic cells.
    Fendrick JL, Iglewski WJ, Moehring JM, Moehring TJ.
    Eur J Biochem; 1992 Apr 01; 205(1):25-31. PubMed ID: 1313365
    [Abstract] [Full Text] [Related]

  • 3. Endogenous ADP-ribosylation for eukaryotic elongation factor 2: evidence of two different sites and reactions.
    Bektaş M, Nurten R, Ergen K, Bermek E.
    Cell Biochem Funct; 2006 Apr 01; 24(4):369-80. PubMed ID: 16142694
    [Abstract] [Full Text] [Related]

  • 4. Reduced ribosomal binding of eukaryotic elongation factor 2 following ADP-ribosylation. Difference in binding selectivity between polyribosomes and reconstituted monoribosomes.
    Nygård O, Nilsson L.
    Biochim Biophys Acta; 1985 Feb 20; 824(2):152-62. PubMed ID: 3970930
    [Abstract] [Full Text] [Related]

  • 5. Cellular ADP-ribosylation of elongation factor 2.
    Iglewski WJ.
    Mol Cell Biochem; 1994 Sep 20; 138(1-2):131-3. PubMed ID: 7898455
    [Abstract] [Full Text] [Related]

  • 6. Nucleotide binding to elongation factor 2 inactivated by diphtheria toxin.
    Burns G, Abraham AK, Vedeler A.
    FEBS Lett; 1986 Nov 24; 208(2):217-20. PubMed ID: 3780964
    [Abstract] [Full Text] [Related]

  • 7. ADP-ribosylated elongation factor 2 (ADP-ribosyl-EF-2) is unable to promote translocation within the ribosome.
    Davydova EK, Ovchinnikov LP.
    FEBS Lett; 1990 Feb 26; 261(2):350-2. PubMed ID: 2311763
    [Abstract] [Full Text] [Related]

  • 8. Cytoplasmic inhibitor of eEF-2 ADP-ribosylation catalyzed by diphtheria toxin or endogenous transferase in rat liver cells.
    Galicka A, Sredzińska K, Gindzieński A.
    Biochem Biophys Res Commun; 2000 Mar 16; 269(2):553-6. PubMed ID: 10708592
    [Abstract] [Full Text] [Related]

  • 9. Kinetic determination of the effects of ADP-ribosylation on the interaction of eukaryotic elongation factor 2 with ribosomes.
    Nygård O, Nilsson L.
    J Biol Chem; 1990 Apr 15; 265(11):6030-4. PubMed ID: 2318846
    [Abstract] [Full Text] [Related]

  • 10. ADP-ribosyltransferase from beef liver which ADP-ribosylates elongation factor-2.
    Iglewski WJ, Lee H, Muller P.
    FEBS Lett; 1984 Jul 23; 173(1):113-8. PubMed ID: 6086394
    [Abstract] [Full Text] [Related]

  • 11. Estimating the amounts of ADP-ribosylatable active elongation factor-2 in mammalian cell-free extracts.
    Riis B, Rattan SI, Clark BF.
    J Biochem Biophys Methods; 1989 Oct 23; 19(4):319-25. PubMed ID: 2693515
    [Abstract] [Full Text] [Related]

  • 12. Separation of the 24 kDa substrate for botulinum C3 ADP-ribosyltransferase and the cholera toxin ADP-ribosylation factor.
    Tsai SC, Adamik R, Moss J, Aktories K.
    Biochem Biophys Res Commun; 1988 May 16; 152(3):957-61. PubMed ID: 3132159
    [Abstract] [Full Text] [Related]

  • 13. Eukaryotic elongation factor 2 loses its non-specific affinity for RNA and leaves polyribosomes as a result of ADP-ribosylation.
    Sitikov AS, Davydova EK, Bezlepkina TA, Ovchinnikov LP, Spirin AS.
    FEBS Lett; 1984 Oct 29; 176(2):406-10. PubMed ID: 6208057
    [Abstract] [Full Text] [Related]

  • 14. Effect of ADP-ribosylation and phosphorylation on the interaction of elongation factor 2 with guanylic nucleotides.
    Marzouki A, Sontag B, Lavergne JP, Vidonne C, Reboud JP, Reboud AM.
    Biochimie; 1991 Oct 29; 73(7-8):1151-6. PubMed ID: 1742357
    [Abstract] [Full Text] [Related]

  • 15. 1-N6-Etheno-ADP-ribosylation of elongation factor-2 by diphtheria toxin.
    Giovane A, Balestrieri C, Quagliuolo L, Servillo L.
    FEBS Lett; 1985 Oct 28; 191(2):191-4. PubMed ID: 2996930
    [Abstract] [Full Text] [Related]

  • 16. Cellular ADP-ribosyltransferase with the same mechanism of action as diphtheria toxin and Pseudomonas toxin A.
    Lee H, Iglewski WJ.
    Proc Natl Acad Sci U S A; 1984 May 28; 81(9):2703-7. PubMed ID: 6326138
    [Abstract] [Full Text] [Related]

  • 17. ADP-ribosylatable content of elongation factor-2 changes during cell cycle of normal and cancerous human cells.
    Riis B, Rattan SI, Cavallius J, Clark BF.
    Biochem Biophys Res Commun; 1989 Mar 31; 159(3):1141-6. PubMed ID: 2930555
    [Abstract] [Full Text] [Related]

  • 18. Purification and properties of an altered form of elongation factor 2 from mutant cells resistant to intoxication by diphtheria toxin.
    Iglewski WJ, Lee H.
    Eur J Biochem; 1983 Aug 01; 134(2):237-40. PubMed ID: 6307688
    [Abstract] [Full Text] [Related]

  • 19. Purification of elongation factor 2 from human placenta and evidence of its fragmentation patterns in various eukaryotic sources.
    Giovane A, Servillo L, Quagliuolo L, Balestrieri C.
    Biochem J; 1987 Jun 01; 244(2):337-44. PubMed ID: 3663126
    [Abstract] [Full Text] [Related]

  • 20. Utilization of 2'-deoxynad for ADP-ribose transfer reactions.
    Wasson DB, Yamanaka H, Carson DA.
    Adv Exp Med Biol; 1989 Jun 01; 253B():213-8. PubMed ID: 2514587
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 7.